603102 Stock Overview
Together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Rewards
Risk Analysis
No risks detected for 603102 from our risk checks.
My Notes
Capture your thoughts, links and company narrative
Weihai Baihe Biology Technological Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥35.20 |
| 52 Week High | CN¥40.56 |
| 52 Week Low | CN¥28.06 |
| Beta | 0.66 |
| 1 Month Change | -1.07% |
| 3 Month Change | 4.70% |
| 1 Year Change | 3.71% |
| 3 Year Change | -48.01% |
| 5 Year Change | n/a |
| Change since IPO | -41.99% |
Recent News & Updates
Little Excitement Around Weihai Baihe Biology Technological Co., Ltd.'s (SHSE:603102) Earnings
Dec 23
Weihai Baihe Biology Technological (SHSE:603102) Could Be Struggling To Allocate Capital
Oct 01Shareholder Returns
| 603102 | CN Personal Products | CN Market | |
|---|---|---|---|
| 7D | 0.6% | -0.08% | 0.07% |
| 1Y | 3.7% | -2.2% | 18.4% |
Return vs Industry: 603102 exceeded the CN Personal Products industry which returned -3.2% over the past year.
Return vs Market: 603102 underperformed the CN Market which returned 15.4% over the past year.
Price Volatility
| 603102 volatility | |
|---|---|
| 603102 Average Weekly Movement | 4.8% |
| Personal Products Industry Average Movement | 5.8% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in CN Market | 10.8% |
| 10% least volatile stocks in CN Market | 4.0% |
Stable Share Price: 603102 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 603102's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 1,120 | Xinli Liu | www.baiheshengwu.com |
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutritional soft candies; special diet products comprising supplementary food and nutritional supplements, nutritional supplements for pregnant women and lactating mothers, and sports nutrition supplements; official approval services for health food declarations; and testing suits services. It provides its products in the form of soft and hard capsules, tablets, powders, oral liquids, drops, and bottles.
Weihai Baihe Biology Technological Co., Ltd. Fundamentals Summary
| 603102 fundamental statistics | |
|---|---|
| Market cap | CN¥2.22b |
| Earnings (TTM) | CN¥157.03m |
| Revenue (TTM) | CN¥845.07m |
14.1x
P/E Ratio2.6x
P/S RatioIs 603102 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 603102 income statement (TTM) | |
|---|---|
| Revenue | CN¥845.07m |
| Cost of Revenue | CN¥542.82m |
| Gross Profit | CN¥302.25m |
| Other Expenses | CN¥145.23m |
| Earnings | CN¥157.03m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Apr 15, 2025
| Earnings per share (EPS) | 2.49 |
| Gross Margin | 35.77% |
| Net Profit Margin | 18.58% |
| Debt/Equity Ratio | 0% |
How did 603102 perform over the long term?
See historical performance and comparisonDividends
2.1%
Current Dividend Yield31%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/29 00:56 |
| End of Day Share Price | 2025/01/27 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Weihai Baihe Biology Technological Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|